9-95508249-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_000264.5(PTCH1):c.113G>A(p.Gly38Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,603,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G38V) has been classified as Likely benign.
Frequency
Consequence
NM_000264.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTCH1 | ENST00000331920.11 | c.113G>A | p.Gly38Glu | missense_variant | Exon 1 of 24 | 5 | NM_000264.5 | ENSP00000332353.6 | ||
PTCH1 | ENST00000437951.6 | c.199-1650G>A | intron_variant | Intron 1 of 23 | 5 | NM_001083603.3 | ENSP00000389744.2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151730Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000917 AC: 21AN: 228974Hom.: 0 AF XY: 0.000103 AC XY: 13AN XY: 126552
GnomAD4 exome AF: 0.000126 AC: 183AN: 1451288Hom.: 0 Cov.: 34 AF XY: 0.000137 AC XY: 99AN XY: 721554
GnomAD4 genome AF: 0.000112 AC: 17AN: 151730Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74090
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
- -
Hereditary cancer-predisposing syndrome Benign:2
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
not specified Uncertain:1
DNA sequence analysis of the PTCH1 gene demonstrated a sequence change, c.113G>A, in exon 1 that results in an amino acid change, p.Gly38Glu. This sequence change has been described in gnomAD with a frequency of 0.016% in the Non-Finnish European sub-population (dbSNP rs143494325). The p.Gly38Glu change affects a moderately conserved amino acid residue located in a domain of the PTCH1 protein that is known to be functional. The p.Gly38Glu substitution appears to be tolerated using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL).One recent study reported an individual with congenital embryonal rhabdomyosarcoma who was compound heterozygous for this variant in PTCH1 and another missense change in the PTCH2 (PMID: 29230040). Due to the lack of sufficient evidences, the clinical significance of the p.Gly38Glu change remains unknown at this time. -
Craniopharyngioma Uncertain:1
- -
Gorlin syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at